| Name | Value |
|---|---|
| Revenues | 270.9M |
| Cost of Revenue | 93.2M |
| Gross Profit | 177.7M |
| Operating Expense | 146.9M |
| Operating I/L | 12.6M |
| Other Income/Expense | 0.7M |
| Interest Income | 1.1M |
| Pretax | 13.3M |
| Income Tax Expense | 4.1M |
| Net Income/Loss | 9.2M |
Penumbra, Inc. is a global medical device company specializing in the design, development, manufacturing, and marketing of a wide range of neurovascular and vascular medical devices. The company's product portfolio includes aspiration-based thrombectomy systems, neurovascular embolization coiling systems, neurovascular access systems, neurosurgical aspiration tools, detachable embolic coil systems, microcatheters, occlusion devices, and immersive computer-based technologies. Penumbra generates revenue through the sale of its medical devices, which are used in various neurovascular and vascular therapies, and are distributed through direct sales organizations and distributors.